BIO-FUNCTION to predict risks after stem cell transplant
This study looks at a new tool called BIO-FUNCTION to help predict the risk of serious complications or death after a stem cell transplant or cellular therapy. The goal is to better understand who might be at higher risk, so doctors can provide more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be scheduled to have a stem cell transplant or cellular therapy.
- You must not be pregnant (if applicable).
- You must not have a serious medical or psychiatric illness that would interfere with study participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at two blood markers to predict the risk of acute graft-versus-host disease after an allogeneic stem cell transplant. If you qualify, your care team may use results to help anticipate and manage complications earlier.
This study looks at changes in your gut bacteria (microbiome) around the time of stem cell transplant. The goal is to understand how these bacteria relate to transplant outcomes, which may help doctors improve care in the future.
This study is for people who have had a stem cell or solid organ transplant. It aims to predict who might get a serious infection and help doctors manage their care better.
This study tests a new blood test to help predict whether acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) will come back after a stem cell transplant. Early detection could help doctors treat relapse sooner.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This study looks at blood markers that might show early complications after a stem cell transplant from a donor. It could help doctors predict problems sooner.
Hear when a new Mortality Prediction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.